| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 630-634, Copyright © 1996 by Endocrine Society
ARTICLES |
M Wakatsuki, Y Shintani, M Abe, ZH Liu, K Shitsukawa and S Saito
First Department of Internal Medicine, University of Tokushima School of Medicine, Japan.
A sensitive and specific immunoradiometric assay for follistatin was developed using antifollistatin mouse monoclonal and rabbit polyclonal antibodies. The sensitivity of the assay was 0.5 micrograms/L, and cross-reactivities with recombinant human activin A and bovine inhibin were less than 0.1%. The intra- and interassay coefficients of variation were less than 10%, and the recovery rate was about 90% in human serum. The addition of activin A to the same sample resulted in a minimal influence on follistatin recovery, indicating that this assay system can measure the total level of activin-bound and unbound follistatin. Gel filtration analysis of human serum showed that the majority of immunoreactivity was eluted in a larger molecular size position than that of free follistatin, suggesting that the large part of follistatin is bound to other proteins, presumably activins, in serum. Using this assay, immunoreactive follistatin levels in various biological fluids and human sera were examined. The dose-response curves of porcine follicular and amniotic fluids were parallel to the standard curve, and porcine follicular fluid contained extremely high follistatin immunoreactivity (5.6 mg/L). The serum follistatin level in normal human volunteers was 13.3 +/- 4.7 micrograms/L (mean +/- SD; n = 60), with a tendency to increase gradually with age. On the other hand, the serum follistatin level was remarkably elevated in pregnant women (62.7 +/- 35.3 micrograms/L; n = 57), with a positive correlation with weeks of pregnancy. These data indicated that circulating immunoreactive follistatin is detectable in human serum, and the levels vary with physiological conditions such as aging and pregnancy.
This article has been cited by other articles:
![]() |
K Rae, K Hollebone, V Chetty, D Clausen, and J McFarlane Follistatin serum concentrations during full-term labour in women significant differences between spontaneous and induced labour Reproduction, November 1, 2007; 134(5): 705 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xia, T. O'Shea, R. Murison, and J.R. McFarlane Concentrations of Progesterone, Follistatin, and Follicle-Stimulating Hormone in Peripheral Plasma Across the Estrous Cycle and Pregnancy in Merino Ewes That Are Homozygous or Noncarriers of the Booroola Gene Biol Reprod, September 1, 2003; 69(3): 1079 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Plevyak, G. M. Lambert-Messerlian, A. Farina, N. P. Groome, J. A. Canick, and H. M. Silver Concentrations of Serum Total Activin A and Inhibin A in Preterm and Term Labor Patients: A Cross-Sectional Study Reproductive Sciences, May 1, 2003; 10(4): 231 - 236. [Abstract] [PDF] |
||||
![]() |
C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium Experimental Biology and Medicine, October 1, 2002; 227(9): 724 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Abe, Y. Shintani, Y. Eto, K. Harada, M. Kosaka, and T. Matsumoto Potent induction of activin A secretion from monocytes and bone marrow stromal fibroblasts by cognate interaction with activated T cells J. Leukoc. Biol., August 1, 2002; 72(2): 347 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Keelan, R. L. Zhou, L. W. Evans, N. P. Groome, and M. D. Mitchell Regulation of Activin A, Inhibin A, and Follistatin Production in Human Amnion and Choriodecidual Explants by Inflammatory Mediators Reproductive Sciences, September 1, 2000; 7(5): 291 - 296. [Abstract] [PDF] |
||||
![]() |
A.E. O'Connor, J.R. McFarlane, S. Hayward, T. Yohkaichiya, N.P. Groome, and D.M. de Kretser Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study Hum. Reprod., March 1, 1999; 14(3): 827 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. McConnell, Q. Wang, P. M. Sluss, N. Bolf, R. H. Khoury, A. L. Schneyer, A. R. Midgley Jr., N. E. Reame, W. F. Crowley Jr., and V. Padmanabhan A Two-Site Chemiluminescent Assay for Activin-Free Follistatin Reveals That Most Follistatin Circulating in Men and Normal Cycling Women Is in an Activin-Bound State J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 851 - 858. [Abstract] [Full Text] |
||||
![]() |
Y. Shintani, M. Dyson, A. E. Drummond, and J. K. Findlay Regulation of Follistatin Production by Rat Granulosa Cells in Vitro Endocrinology, June 1, 1997; 138(6): 2544 - 2551. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |